The prescriber as moralist: values
in the antidepressant debate
by
Scheurich N.
Department of Psychiatry,
University of Kentucky College of Medicine,
3470 Blazer Parkway, Lexington, 40509, USA.
nesche2@uky.edu.
Perspect Biol Med. 2006 Spring;49(2):199-208.

ABSTRACT

The past decade has seen a growing debate about the expanding use of psychotropic medications. Of particular concern are current antidepressants, as well as hypothetical "mood brighteners" that could modify affect and behavior in people heretofore classified as being within the normal range. This paper argues that objections to such pharmacologic applications are based on appeals to cultural values--authenticity, diversity, inwardness, and stoicism among others--that are viewed as being under increasing threat in contemporary American culture. Critiques of mood brighteners, like critiques of technological, consumer-driven culture, repudiate the ideals of shallow satisfaction and of the self as commodity. The decision to prescribe or not to prescribe a psychotropic medication in any given case is based on cultural values as well as clinical judgment.

SSRIs
Options
Bupropion
Amineptine
Reboxetine
Mechanisms
Nefazodone
Mirtazapine
Venlafaxine
Antidepressants
Antidepressants
Tranylcypromine
Anti-anxiety drugs
Chronic depression
Atypical depression
Retarded depression
Treatment-resistant depression
The monoamine theory of depression

Refs
HOME
HedWeb
Cocaine.org
Future Opioids
BLTC Research
Superhappiness?
Paradise-Engineering
The Hedonistic Imperative
MDMA: Utopian Pharmacology

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family